Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Pharmacology
|
March 22, 2012
Off-target cannabinoid effects mediated by GPR55
Christopher M Henstridge
The European Journal of Neuroscience
|
June 28, 2018
FENS-Kavli winter symposium: Addressing the cellular phase of dementia-visions of the UK Dementia Research Institute
Raphael Hesse, Christopher M Henstridge
Neuronal Signaling
|
October 3, 2022
Array tomography: 15 years of synaptic analysis
Anna Sanchez Avila, Christopher M Henstridge
Nature Neuroscience
|
June 29, 2018
Modeling Alzheimer's disease brains in vitro
Christopher M Henstridge, Tara L Spires-Jones
Frontiers in Cellular Neuroscience
|
March 14, 2019
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Christopher M Henstridge, Makis Tzioras, Rosa C Paolicelli
Trends in Endocrinology and Metabolism: TEM
|
May 25, 2016
GPR55: Metabolic Help or Hindrance?
Christopher M Henstridge, Andrew J Brown, Maria Waldhoer
Ageing Research Reviews
|
April 25, 2016
Synaptic pathology: A shared mechanism in neurological disease
Christopher M Henstridge, Eleanor Pickett, Tara L Spires-Jones
Nature Reviews. Neuroscience
|
January 16, 2019
Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis
Christopher M Henstridge, Bradley T Hyman, Tara L Spires-Jones
Advances in Pharmacology (San Diego, Calif.)
|
September 13, 2011
Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55
Nariman A B Balenga, Christopher M Henstridge, Julia Kargl, et al.
Molecular Pharmacology
|
December 22, 2006
An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor
Neil A McDonald, Christopher M Henstridge, Christopher N Connolly, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Pharmacology
|
March 22, 2012
Off-target cannabinoid effects mediated by GPR55
Christopher M Henstridge
The European Journal of Neuroscience
|
June 28, 2018
FENS-Kavli winter symposium: Addressing the cellular phase of dementia-visions of the UK Dementia Research Institute
Raphael Hesse, Christopher M Henstridge
Neuronal Signaling
|
October 3, 2022
Array tomography: 15 years of synaptic analysis
Anna Sanchez Avila, Christopher M Henstridge
Nature Neuroscience
|
June 29, 2018
Modeling Alzheimer's disease brains in vitro
Christopher M Henstridge, Tara L Spires-Jones
Frontiers in Cellular Neuroscience
|
March 14, 2019
Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration
Christopher M Henstridge, Makis Tzioras, Rosa C Paolicelli
Trends in Endocrinology and Metabolism: TEM
|
May 25, 2016
GPR55: Metabolic Help or Hindrance?
Christopher M Henstridge, Andrew J Brown, Maria Waldhoer
Ageing Research Reviews
|
April 25, 2016
Synaptic pathology: A shared mechanism in neurological disease
Christopher M Henstridge, Eleanor Pickett, Tara L Spires-Jones
Nature Reviews. Neuroscience
|
January 16, 2019
Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis
Christopher M Henstridge, Bradley T Hyman, Tara L Spires-Jones
Advances in Pharmacology (San Diego, Calif.)
|
September 13, 2011
Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55
Nariman A B Balenga, Christopher M Henstridge, Julia Kargl, et al.
Molecular Pharmacology
|
December 22, 2006
An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor
Neil A McDonald, Christopher M Henstridge, Christopher N Connolly, et al.
Page
of 5